INTRALYTIX INC

Basic Information

351 W CAMDEN ST STE 100
Baltimore, MD, 21201-8603

http://www.intralytix.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 5318758
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 11


  1. Bacteriophages for reducing Vibrio tubiashii associated mortality of shellfish

    Amount: $99,991.00

    This project aims to develop a phage-based product (VTP-100) that will contain a mixture of lytic phages effective against a variety of hatchery strains of Vibrio tubiashii. V. tubiashii is a major ca ...

    SBIR Phase I 2013 Department of Agriculture
  2. Phage preparation for managing Salmonella in foods

    Amount: $449,865.00

    Salmonellae continue to be one of the leading worldwide causes of foodborne bacterial diseases. They cause 1.2-1.4 million annual cases of salmonellosis in the USA, with associated costs estimated to ...

    SBIR Phase II 2012 Department of Agriculture
  3. Development of phage preparation for managing Salmonella in foods

    Amount: $99,984.00

    Our project envisions developing a bacteriophage-based product, designated SalmoShield, for eliminating or significantly reducing contamination of poultry products (and eventually other foods) with Sa ...

    SBIR Phase I 2011 Department of Agriculture
  4. Bacteriophage-based probiotic preparation for managing Shigella infections

    Amount: $749,969.00

    During the studies supported by our Phase I STTR grant from the US Army, we began developing and testing a novel concept for a probiotic preparation based on naturally occurring bacteriophages as a ...

    STTR Phase II 2011 ArmyDepartment of DefenseDepartment of Defense
  5. Bacteriophage-based probiotic preparation for managing Shigella infections

    Amount: $99,997.00

    Diarrhea remains a major public health challenge worldwide, and it also may significantly hamper US troop operations during combat and peacekeeping missions overseas. Antibiotics can be used to treat ...

    STTR Phase I 2009 Defense Advanced Research Projects AgencyDepartment of DefenseDepartment of Defense
  6. Bacteriophage therapy for treating A. baumannii infected wounds

    Amount: $99,991.00

    Treatment of bacterial-infected wounds is one the most critical problems in modern medicine, and it presents one of the most significant challenges for US troops during combat operations. The managem ...

    STTR Phase I 2009 Defense Advanced Research Projects AgencyDepartment of DefenseDepartment of Defense
  7. Bacteriophage-based probiotic preparations and their effect on the gut microflora

    Amount: $269,232.00

    DESCRIPTION (provided by applicant): The human gastrointestinal (Gl) tract is colonized by an abundant and diverse microbiota. Numerous factors (e.g., antibiotic treatment, diet, etc.) may alter the n ...

    SBIR Phase I 2007 Department of Health and Human Services
  8. Development of a phage-based technology for eliminating or significantly reducing contamination of fruits, vegetables, and red meat with E. coli O157:

    Amount: $729,993.00

    The availability of approaches which reduce contamination of foods with bacterial pathogens is of paramount importance for ensuring the safety and operational readiness of US troops worldwide, as well ...

    SBIR Phase II 2007 ArmyDepartment of DefenseDepartment of Defense
  9. Development of a phage-based technology for eliminating or significantly reducing contamination of fruits and vegetables with E. coli O157:H7

    Amount: $69,995.00

    Foodborne illnesses of microbial origin continue to be serious food safety problems worldwide, and they also may substantively hamper military operations. Thus, the availability of approaches which s ...

    SBIR Phase I 2006 ArmyDepartment of DefenseDepartment of Defense
  10. N/A

    Amount: $99,929.00

    N/A

    STTR Phase I 2000 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government